ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ("GeoVax" or the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it will move its corporate headquarters and laboratory operations from the Briarcliff campus of Emory University to Smyrna, Georgia, a northwest suburb of Atlanta, effective November 3, 2009.
The Company has been housed in the Emtech Bio incubator facility (a partnership between Emory University and Georgia Institute of Technology) since its formation in 2001. The new location at 1900 Lake Park Drive, Suite 380, Smyrna, Georgia 30080, will encompass over 8400 square feet of office and laboratory space. The Company will occupy this new headquarters under a 62-month lease. The facility is situated within an existing biotech building in a controlled-access campus, and will house all of the Company's U.S. research and development, process engineering, quality control, regulatory and administrative operations.
Bob McNally, Ph.D., GeoVax's President and Chief Executive Officer stated, "This move will give GeoVax much-needed additional space for our current activities, as well as providing space to accommodate the addition of several new employees to our research and development staff and the resulting expansion of our operations. The new facility will offer suitable space for our corporate needs while keeping our overall facility expenses in line. We appreciate the years of support from Emory University, Georgia Tech and the Georgia Research Alliance, all entities that were instrumental in contributing space and equipment while the Company was in its initial development phases. Our move is not only physical, but represents the continuing growth of GeoVax's leadership position in HIV vaccine technology."
|SOURCE GeoVax Labs, Inc.|
Copyright©2009 PR Newswire.
All rights reserved